Skip to main content
NCBI home page
PLOS One logoLink to PLOS One
. 2015 Jul 2;10(7):e0132647. doi: 10.1371/journal.pone.0132647

Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients

Giuseppina Rosaria Rita Ricciardi, Barbara Adamo, Antonio Ieni, Luana Licata, Roberta Cardia, Giuseppa Ferraro, Tindara Franchina, Giovanni Tuccari, Vincenzo Adamo
PMCID: PMC4489771  PMID: 26135303

There are a number of errors in the caption of Fig 1. Please see the complete, correct Fig 1 caption here.

Fig 1. The E-cadherin, Ki-67 and AR expression in 45 patients TNBC.

Fig 1

Open in a new tab

Legend: [A, B] E-cadherin negative/positive staining; [C,D] Ki-67 level < or ≥ 20%; [E,F] negative/positive AR staining.

Reference

  • 1. Ricciardi GRR, Adamo B, Ieni A, Licata L, Cardia R, Ferraro G, et al. (2015) Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. PLoS ONE 10(6): e0128368 doi: 10.1371/journal.pone.0128368 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES